sition 151 by Ser. Analysis of the healthy members of the family and 100 unrelated controls showed a normal sequence of the EFNB1 gene. Phenotypes of the patients in this family differ from the classical CFNS due to the decreased size of sulci and fissures, subarachnoid space and ventricles, and the absence of a cleft lip/palate.
family with CNFS and a mutation in the EFNB1 gene. In contrast to the features present in the 2 families previously reported, however, our family did not have cleft lip/ palate [Twigg et al., 2004; Özylmaz et al., 2015] . In addition, the family showed clinical data that were not previously observed in CFNS patients with mutations in the EFNB1 gene, representing an expanded phenotype.
Materials and Methods

Patients
The proband (case III-1), a 6-year-old girl, is the first child of healthy, nonconsanguineous young parents at the time of delivery. Family history was negative for intellectual disability or short stature. No history of prenatal exposure to teratogens or maternal illness was recorded. Following an uneventful pregnancy, the proband was born by caesarean section at 40 weeks' gestation with a weight of 2,800 g (10th percentile), height of 54 cm (97th percentile) and an OFC of 34 cm (10-25th percentile). Her Apgar scores were 7 and 8 at 1 and 5 min, respectively. The neonate did not require special management. Her motor and language development has been normal. The parents reported that at the age of 5 years, 2 molars were easily fractured when chewing solid food. On physical examination in the present study, it was found that the patient weighed 17.6 kg (5th percentile), measured 112 cm in height (25-50th percentile) and had an OFC of 48 cm (<3rd percentile). She showed brachycephaly with temporary bulge, a broad metopic area with frontal bossing and lateral narrowing, facial asymmetry, ocular hypertelorism with a pupillary distance of 7.5 cm, an intercanthal distance of 4.3 cm, and upslanting palpebral fissures with a length of 3.1 cm. She had a broad nasal bridge and a bifid nasal tip with a distance between nostrils of 3.5 cm, a downslanting oral commissure ( fig. 1 B) , a short neck, and split nails. Her toes exhibited wide spacing, distal hypoplasia and syndactyly of toes 2-3 ( fig. 1 C, D) . Spinal column X-rays showed mild thoracic scoliosis, and a foot X-ray showed synostosis of the second to fourth interphalangeal joints of the left toes ( fig. 1 E) . 3D CT showed plagiocephaly with a prominent front and flattened side, and absent left coronal suture. Brain MRI showed narrowing of the sulci and fissures, the subarachnoid space and the lateral and third ventricles ( fig. 1 F, G) .
The mother (case II-3), a 26-year-old female, is the daughter of nonconsanguineous young parents, after a normal pregnancy, without consumption of teratogens or aggregated illnesses. Weight, size, and OFC at birth and further growth parameters were not recorded. She had had broken teeth since childhood when chewing solid food. Her intellectual development was normal. She weighed 44.5 kg (<3rd percentile), measured 141 cm in height (<3rd percentile) and had an OFC of 49 cm (<3rd percentile). She showed a brachycephalic skull with temporal bulging and frontal flattening, pinnae with dysplasia (antihelix-helix) and ocular hypertelorism with a pupillary distance of 8.5 cm, intercanthal distance of 5.0 cm and palpebral fissures directed upwards with a length of 3.5 cm. The eyeballs showed right divergent strabismus, and she had a broad nasal bridge and a bifid nasal tip (distance between nostrils: 3.5 cm), a slightly downslanting oral commissure ( fig. 1 B) , a short neck, and split nails. She had normal hands and feet.
The brother of our proband (case III-2), a 4-year-old boy, showed skull dolichocephaly with slight hypertelorism and frontal bossing ( fig. 1 B) . He weighed 13.8 kg (<3rd percentile), measured 100 cm in height (25-50th percentile) and had an OFC of 49 cm (3rd-10th percentile). Apparently, the maternal grandmother, maternal brother and a 7-month-old girl cousin had a similar phenotype as seen in our proband, but it was not possible to examine these patients.
EFNB1 Gene Analysis
After genomic DNA extraction using conventional methods, the EFNB1 gene was analyzed by PCR. The conditions and primers to amplify exons 1-5 of the EFB1 gene were designed as follows: forward F1: 5 ′ -AGAGCGACACCGAAGCCGGC-3 ′ ; reverse R1: 5 ′ -CGCTCCTCCTCCGAAGACCT-3 ′ ; F2/3: 5 ′ -GAGGCTGAC-CATCTTCTTCC-3 ′ ; R2/3: 5 ′ -ACCCAGCCAGGAACATCT-GT-3 ′ ; and F4/5: 5 ′ -CCTGCCTCTCACCTGTTC TG-3 ′ ; R4/5: 5 ′ -TACAAAGGTGGGCACAGCTG-3 ′ . PCR products obtained from the proband, brother, mother, and 100 normal controls in the study were sequenced on an ABI 3730 automated sequencer (PE Biosystems, Foster City, Calif., USA).
EFNB1 3D Protein Prediction
Data on alignment of the protein were obtained from the RaptorX server [Källberg et al., 2012] ; models were viewed in a SwissPdb Viewer, version 4.0, and homology modeling was carried out using SWISS-MODEL [Arnold et al., 2006] .
Results
DNA analysis of the proband, her mother and her brother showed a normal amplification of exons 1-5. DNA sequencing analysis showed a c.451G>A missense mutation within exon 3 of the EFNB1 gene (GRcH38, chrX: 68,839,708; GERP score in hg38 of 9.961; http:// genome.ucsc.edu/cgi-bin/hgTracks; fig. 1 H) , which was previously reported as pathogenic. This mutation leads to a substitution of glycine at position 151 by a serine (p.G151S). Analysis of the unaffected members of the family and 100 healthy controls showed a normal sequence of the EFNB1 gene. No other nucleotide variations or polymorphisms were found in the rest of the analyzed exons.
Modeling of EFNB1 (Ephrin-B1; Uniprot P98172) Protein
Structural change predictions of the mutant form of EFNB1 (p.G151S) revealed that the p.G151S mutation occurred between the β-9 chain and the α-3 helix, which produced a change in the β-12 (it moved) and β-14 (lengthened by 3 amino acids) chains and formed a new β-15 chain in the final C-extreme. It was also observed that α-4 was shortened by 1 amino acid, α-5 moved and α-6 helix was shortened by 2 amino acids, all of which caused a rotation and folding in the extracellular domain of the EFNB1 protein. Energy-computed analysis (the implementation of Swiss-Pdb Viewer on GROMOS96) of the alignment of EFNB1 amino acids with total electron density or electrostatic potential maps in the wild type represented 5,486.521 kJ/mol, whereas the mutant represented 4,598.287 kJ/mol. These data suggest that a mutation of p.G151S annuls the surface area of interaction in the extracellular domain with its Eph receptor due to a rotated and folded EFNB1 protein ( fig. 2 ).
Discussion
Our CFNS family showed the p.G151S mutation previously found in 3 sporadic cases and 2 families [Young, 1987; Orr et al., 1997; Twigg et al., 2004; Özylmaz et al., 2015] . Clinically, our proband exhibited partial syndactyly between toes 2 and 3 of both feet, which was absent in the rest of the family, as described in the previous cases with the p.G151S mutation. Cleft lip/palate was absent in our family and in the 3 previous sporadic cases [Orr et al., 1997; Twigg et al., 2004] ; nevertheless, it was present in 2 families with CFNS [Twigg et al., 2004; Özylmaz et al., 2015] , denoting that the p.G151S mutation has clinical heterogeneity. Familial mutations in the EFNB1 gene have been observed in about 25%, cleft lip/palate is present in 30% and cutaneous syndactyly of the hands and/or feet occurs in about 25% of the cases [Twigg et al., 2004 [Twigg et al., , 2013 . Dental anomalies, such as crowding of the teeth, are observed in 23% of CFNS cases. In this study, we described brittle teeth in our proband and her mother, data that were not observed previously. A previous report suggested that EphB/Ephrin-B molecules are important for perivascular dental pulp stem cell migration toward the dentin surfaces and differentiation into functional odontoblasts; anomaly of Ephrin-B1 due to p.G151S mutation could be responsible for affecting the teeth [Arthur et al., 2009] . In addition, our proband showed synostosis of the interphalangeal joints of the left foot, and a decreased size of the sulci and fissures, subarachnoid space, lateral ventricles and third ventricle, data not previously reported in patients with CFNS and mutations in the EFNB1 gene. These clinical features could be considered in the phenotypic spectrum of patients with CFNS.
The EFNB1 gene is located in Xq13.1, encodes the EFNB1 protein, comprises 5 exons and spans 13.17 kb. The EFNB1 transmembrane ligand protein binds to Eph receptor tyrosine kinases, which are crucial for migration, adhesion and repulsion during neural, vascular and epithelial development. Loss of Ephrin-B1 leads to abnormal cartilage segmentation and the formation of additional skeletal elements [Compagni et al., 2003] . The X-linked dominant inheritance of CFNS is clinically unexpected because women are more severely affected than men; apparently, this stems from the random X inactivation in heterozygous females. Males with severe phenotypes similar to those of heterozygous women may have postzygous mutations of the EFNB1 gene brought about through the mechanism of metabolic or cell interference [Wieland et al., 2005; Twigg et al., 2013] . The inter-and intrafamilial clinical variability could correlate with the patchy or mosaic distribution of EFNB1 expression observed in the limbs of heterozygous mice with random X chromosome inactivation. Moreover, a marked EFNB1 overexpression in X chromosomes bearing the wild-type active allele has been reported [Compagni et al., 2003] , suggesting that the malformation depends on the cells or tissues involved. Our modeling analysis showed a conformational change in the β-chains and α-helices, which produced an abnormal folding and rotation of the extracellular domain of the EFNB1 protein; such data have not been shown in previous studies involving this p.G151S mutation. Searching in the Data Browser of the Exome Variant Server (http://evs.gs.washington.edu/EVS/) and in the Human Gene Mutation Database (http://www.hgmd. cf.ac.uk/ac/index.php), we found that this particular mutation in the EFNB1 gene is present in CFNS showing clinical heterogeneity, including some cases with no clinical features [Özylmaz et al., 2015] .
In contrast, the Grantham Matrix Score for the transition of glycine to serine is 56, a relatively low score that suggests a limited effect of this mutation on the protein function [Grantham, 1974] . Nevertheless, the molecular modeling study indicated a highly significant impact; this analysis underscores the limitations of bioinformatic estimates of the effects of mutations.
In conclusion, this study described a family with CFNS and a p.G151S mutation in the EFNB1 gene with an expanded phenotype. In addition, the modeling protein showed that the p.G151S mutation produced an abnormal folding, which caused malfunction of the EFNB1 protein.
